To print this article, all you need is to be registered or login on Mondaq.com.
Intellectual Property Practice Leader Anthony Insogna discusses
how Jones Day can develop a strong IP plan for your company, the
Firm's experience litigating IP, and the future of protecting
life sciences IP.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
The ever-changing healthcare policy landscape will witness at the federal level regulatory changes driven by the need to transform healthcare delivery, quality and innovation.
A bill introduced by a bipartisan group of Select Committee Members in the Senate and the House could severely impact U.S. companies' ability and desire to contract with biotechnology...
"[The] sin was methodological inconsistency[.]" The Sixth Circuit recently affirmed an MDL court's exclusion of the plaintiffs' only general causation expert and subsequent grant of summary...
In January 2024, the U.S. Government Accountability Office (GAO) issued a report highlighting current obstacles to the U.S. Food and Drug Administration's (FDA) timely and effective regulation...
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.